BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
CONDITION

Evidence-Based Compounds for Acne

Acne vulgaris involves sebaceous gland hyperactivity, Cutibacterium acnes colonisation, follicular hyperkeratinisation, and inflammatory cascade activation. Compounds with clinical evidence for sebum regulation, anti-bacterial activity, anti-inflammatory action, and skin barrier support are ranked below by evidence strength.

Ranking Methodology
Compounds are ranked using a four-signal weighted model: BiohacksAI discovery score (cross-study convergence across targets), target match (direct overlap with AR, TLR2, IL1B and related targets — highest differentiating signal), pathway overlap with INFLAMMATION and TESTOSTERONE HORMONES pathways, and PubMed study count (log-scaled). Clinical drugs are excluded.
Key Biological Targets

Click a target to see all compounds with documented interactions in the BiohacksAI corpus.

Related Conditions

This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.

Browse all compounds · Biological pathways · Molecular targets · All conditions

© Organiq Sweden AB · Patent pending EVE-PAT-2026-001